[
    [
        {
            "time": "2022-12-23",
            "original_text": "华鲁恒升(600426)事件点评：第三期限制性股权激励方案落地 骨干激励机制进一步完善",
            "features": {
                "keywords": [
                    "华鲁恒升",
                    "股权激励",
                    "骨干激励机制"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华鲁恒升(600426)事件点评：第三期限制性股权激励方案落地 骨干激励机制进一步完善",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-12-23",
            "original_text": "一把砸25亿！高瓴又出手了",
            "features": {
                "keywords": [
                    "高瓴",
                    "投资",
                    "资金流入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "一把砸25亿！高瓴又出手了",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-12-23",
            "original_text": "【国金晨讯】传媒互联网2022年度策略：关注元宇宙技术的持续迭代；下调华鲁恒升盈利预测",
            "features": {
                "keywords": [
                    "元宇宙",
                    "华鲁恒升",
                    "盈利预测下调"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "传媒互联网",
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【国金晨讯】传媒互联网2022年度策略：关注元宇宙技术的持续迭代；下调华鲁恒升盈利预测",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-12-23",
            "original_text": "26股获券商买入评级，天康生物目标涨幅达43.56%",
            "features": {
                "keywords": [
                    "券商评级",
                    "天康生物",
                    "目标涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "26股获券商买入评级，天康生物目标涨幅达43.56%",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-12-23",
            "original_text": "12月23日42只个股获券商关注，奥康国际目标涨幅达45.86%",
            "features": {
                "keywords": [
                    "券商关注",
                    "奥康国际",
                    "目标涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "12月23日42只个股获券商关注，奥康国际目标涨幅达45.86%",
                "Correlation": 3,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]